Dr Philippe Beuzeboc

Spécialité

Oncologue médical, expert urologie

Titre

Chef de département

Hôpital

Hôpital Foch (Suresnes)

Derniers articles

• The genomic and transcriptomic landscape of metastastic urothelial cancer. (4 oct. 2024)
• Early-phase clinical trials in oncology for adults in France: A preliminary empirical bioethics study. (5 sept. 2024)
• Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer. (1 août 2024)
• Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. (31 mai 2024)
• A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer. (1 janv. 2024)